We are here to modernize
women's healthcare
Gynecologic care made easy
In-office process
Champions the move to local doctor’s offices without the need or expense of a specialized clinic.
More efficient
Eliminates the need for surgery and associated specialists/costs: surgical theater, anesthesia, etc.
Low-cost
Our procedures reimburse at rates that allow for the clinicl. Favorable economics for diagnosis lead to treatments that solve the patient problem while also allowing physician access to reimbursable treatments.
AI Driven Data Innovation
We utilize AI and machine learning. Effective data collection is not enough. Clinicians need refined analytics that lead to precision diagnosis. With Butterfly
Our mission
Develop novel technologies enabling everyone to access safe, effective, and affordable gynecologic and fertility care.
Our technology scales to treatments
Our unique technology can be applied in fertility treatment. We enable an enhanced IVF clinical experience through visualization, tip articulation, device miniaturization and AI/ML driven intrauterine insights that identify pathologies that cause infertility.
​
Our technology and platform is not limited to diagnostic utilization, we can also treat We will also expand our platform for use in basic uterine health procedures (polyp, cyst, fibroid removal) and enhanced IVF through embryo implantation. With our visual embryo transfer system, which provides direct visualization of catheter placement in the uterus, and coupled with pathology identification that reduces the risk of undetected pathology, we can significantly increase pregnancy rates in IVF.
Our trajectory
We are currently pre-market and have reached a minimum viable product for our product utilizations of Visual SIS (physiologic / molecular diagnostics, visual embryo transfer .
Commercialization activities will commence in 2025 and 2026 with market entry in 2027 upon FDA 510K clearance.
